NRX Pharmaceuticals, Inc. (NRXP) Free cash flow 2020–2024
NRX Pharmaceuticals, Inc. (NRXP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.6MFY2024 · since FY2020: -$2.3M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$10.6M | +50.9% |
| FY2023 | -$21.7M | +45.5% |
| FY2022 | -$39.8M | -5.4% |
| FY2021 | -$37.7M | -1563.4% |
| FY2020 | -$2.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice